HTML has links - PDF has Authentication

Chapter 246-922 WAC

|Show DispositionsLast Update: 12/19/23

PODIATRIC PHYSICIANS AND SURGEONS

WAC Sections

HTMLPDF246-922-001Scope of practice.
HTMLPDF246-922-010Definitions.
HTMLPDF246-922-020Board officers.
HTMLPDF246-922-030Approved schools of podiatric medicine.
HTMLPDF246-922-032Postgraduate podiatric medical training defined.
HTMLPDF246-922-033Eligibility for licensure.
HTMLPDF246-922-035Temporary practice permit.
HTMLPDF246-922-036Temporary practice permit—Military spouse eligibility and issuance.
HTMLPDF246-922-040Examinations.
HTMLPDF246-922-050Identification of licensees.
HTMLPDF246-922-055Reciprocity requirements.
HTMLPDF246-922-060Presumption of responsibility for advertisements.
HTMLPDF246-922-080Advertisements prior to licensure prohibited.
HTMLPDF246-922-130Mandatory reporting.
HTMLPDF246-922-200Professional and ethical standards.
HTMLPDF246-922-210Patient abandonment.
HTMLPDF246-922-230Prohibited transactions.
HTMLPDF246-922-235Prohibited publicity and advertising.
HTMLPDF246-922-240Soliciting patients.
HTMLPDF246-922-260Maintenance of patient records.
HTMLPDF246-922-270Inventory of legend drugs and controlled substances.
HTMLPDF246-922-285Retired active credential.
HTMLPDF246-922-290Inactive credential.
HTMLPDF246-922-295Expired license.
HTMLPDF246-922-300Podiatric continuing medical education required.
HTMLPDF246-922-310Categories of creditable podiatric continuing medical education activities.
HTMLPDF246-922-400Intent of substance abuse monitoring.
HTMLPDF246-922-405Definitions used relative to monitoring of applicable impairing health conditions.
HTMLPDF246-922-410Approval of monitoring programs.
HTMLPDF246-922-415Participation in monitoring programs.
HTMLPDF246-922-500Adjudicative proceedings.
HTMLPDF246-922-600Sexual misconduct.
HTMLPDF246-922-620Abuse.
HTMLPDF246-922-650Safe and effective analgesia and anesthesia administration in office-based settings.
OPIOID PRESCRIBING—GENERAL PROVISIONS
HTMLPDF246-922-660Intent and scope.
HTMLPDF246-922-661Exclusions.
HTMLPDF246-922-662Definitions.
HTMLPDF246-922-675Patient notification, secure storage, and disposal.
HTMLPDF246-922-680Use of alternative modalities for pain treatment.
HTMLPDF246-922-685Continuing education requirements for opioid prescribing.
OPIOID PRESCRIBING—ACUTE NONOPERATIVE PAIN AND ACUTE PERIOPERATIVE PAIN
HTMLPDF246-922-690Patient evaluation and patient record.
HTMLPDF246-922-695Acute nonoperative pain.
HTMLPDF246-922-700Acute perioperative pain.
OPIOID PRESCRIBING FOR SUBACUTE PAIN
HTMLPDF246-922-705Patient evaluation and patient record.
HTMLPDF246-922-710Subacute pain.
OPIOID PRESCRIBING—CHRONIC PAIN MANAGEMENT
HTMLPDF246-922-715Patient evaluation and patient record.
HTMLPDF246-922-720Treatment plan.
HTMLPDF246-922-725Written agreement for treatment.
HTMLPDF246-922-730Periodic review.
HTMLPDF246-922-735Consultation—Recommendations and requirements.
HTMLPDF246-922-740Consultation—Exemptions for exigent and special circumstances.
HTMLPDF246-922-745Consultation—Exemptions for the podiatric physician.
HTMLPDF246-922-750Pain management specialist.
HTMLPDF246-922-755Evaluation of, or change in, treatment plan.
HTMLPDF246-922-760Patients with chronic pain, including those on high doses—Establishing a relationship with a new podiatric physician.
OPIOID PRESCRIBING—SPECIAL POPULATIONS
HTMLPDF246-922-765Special populations—Patients twenty-five years of age or under, pregnant patients, and aging populations.
HTMLPDF246-922-770Episodic care of chronic opioid patients.
OPIOID PRESCRIBING—COPRESCRIBING
HTMLPDF246-922-775Coprescribing of opioids with certain medications.
HTMLPDF246-922-780Coprescribing of opioids for patients receiving medication assisted treatment.
HTMLPDF246-922-785Coprescribing of naloxone.
OPIOID PRESCRIBING—PRESCRIPTION MONITORING PROGRAM
HTMLPDF246-922-790Prescription monitoring program—Required registration, queries, and documentation.
HTMLPDF246-922-990Podiatry fees and renewal cycle.